Onward with durable remission

Posted by edmond1971 @edmond1971, Oct 12, 2024

I add bits of pieces of my story to various posts, but I'm organizing my story and figured this would be a good opportunity to share with the crew on the forum!

Chapter 1: The original diagnosis of Prostate Cancer (PCa) in December 2012 (Age 41) with a PSA of 3 and biopsy showed 7 out of 12 cores positive with GS of 6(3+3). Had RALP in June 2013 and pathology showed clear margins and revised GS of 7(3+4). Recovery from surgery quite well with no incontinence and with intentional action the erectile function came back to life. PSA was zero for a few years and I stopped testing in 2016.

Chapter 2: Routine physical August 2022 (Age 51) showed PSA of 9.0 and subsequent tests had PSA rising to 19.0 by October 2022. Imaging (Bone, MRI, CT) showed nothing and then a PSMA PET showed that PCa had metastasized to 25+ lymph nodes only, primarily in the iliac region, a bit in upper pelvic, and one spot on clavicle. The health team suggested a triplet treatment (ADT, ARSI, CHEMO) but with a new job starting soon, I went with ADT(Leuprolide (Eligard) via 3-month injection in Late October 2022. In January 2023 (month 3) the PSA dropped to 0.4 and we added in ARSI (daily Abiraterone Acetate (Zytiga) with Prednisone) and PSA dropped to < 0.1 (month 6) and has remained such through late September 2024. Did perform genetic testing and confirmed for BRCA2, have done many other tests and actions for skin, pancreas, liver, colon and all things are looking good with no signs of any other cancers. The side effects of ADT are real, significant, and can be managed. I do monitor my blood pressure daily and the ARSI didn’t have adverse effects.

Chapter 3: Now in October 2024 (Age 53) entering durable remission and no longer on any treatment. The health team outlook is a probable modest recovery of testosterone in 6-15 months, and likely that the PCa will come back, but when that happens, where it happens, and IF it happens are unknown, so we are moving forward with an optimistic outlook.

Future Game Plan specifics: I am doing a PSA and Testosterone test in December 2024 and February 2025 and aiming to visit the health team in early February 2025. We have reviewed the next steps for any recurrence, it likely will be a PSMA PET to see where it has come back, and some form of IMRT will be explored if the metastases are not as widespread as my original scan. Getting back on the same couplet treatment (ADT + ARSI) will be in the cards as well. Options may exist to add a PARP inhibitor such as Olaparib to the mix, and in the toolkit remains the option for some Chemotherapy (Docetaxel).

I will take all the curve balls of life, bring them on, and hopefully add to the mix a healthy dose of adventure with more energy as I crawl out of the fatigue and brain fog!

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Hi northoftheborder

Yep the historical nature of all the data seems to overshadow its meaningfulness almost by definition for a changing treatment/management situation….. I think the overall survival increases by new and improved metastatis cure/management are coloring my views on longterm ADT…… however I guess I will find out … one way or another….Des

REPLY
@rocky999

Thankyou Jeffmarc for your cautionary tale….. I keep feeling it’s a crap shoot at some level ! I guess I hope that they come up with a non singular marker(s) for BCR. One concept I am holding onto is monthly testing …. although non PSA producing metastasis would confound that …. so trying to build some imaging into the surveillance would be good?

Jump to this post

Unfortunately, Rocky, it IS a crapshoot when it comes to actually ‘seeing’ what’s going on at a cellular level.
PSA’s and PSMA’s are NOT infallible - not even close - but right now it’s what they use to measure success or failure.
I read your brief history and in spite of all the intense genetic testing you had done at the center of excellence, the factors which stand out to me the most are your dangerously high Decipher Score and PSA velocity after surgery.
My surgical pathology was Gleason 4+3, clean margins, no lymph spread, etc. There was no Decipher test at that time. It took 5 years for my PSA to reach .18 and I just finished salvage radiation and am on 6 months ORGOVYX ( last month).
Now if I’m on 6 months ADT for something that took 5 YEARS to return, how long should you be on it, when your PSA rose so quickly after surgery and your Decipher Score showed such an aggressive profile?
It would seem to me as a layman that all things being equal, you should be on it longer than 6 months….how long I certainly don’t know. Orgovyx is really not that bad and others on the forum have been on it for over a year with no significant side effects. I realize you are concerned with your situation becoming castrate resistant if you stay on ADT too long but I think you’d have to be on it for a much longer time for that to happen. Best…

REPLY

There are lots of ways to address PC; as this blog explains, there are personal decisions to make. After my surgery, I learned that my cancer had spread to at least one lymph node. I decided to try the Mediterranean Diet and have my PSA tested every three months. It’s been three years now and my PSA has stayed at the undetectable level which I’m grateful.

REPLY
@northoftheborder

Thanks for sharing that. Just a note that that abstract for that study says it uses data from 1999–2004 for patients with PSA levels from 0.1 to 2.0. As far as I know, those predate the ultrasensitive PSA test (or at least its wide availability). I haven't yet found a study mentioning major metastases with undetectable levels in the uPSA test (< 0.01, or sometimes even lower), but am keeping my eyes open.

Regardless, even for the old data with the less sensitive PSA tests, they were looking at something that happened only very rarely.

Jump to this post

Interesting point you bring up. Unfortunately there is no answer today, hopefully this is being studied. An awful lot of people want an answer to this, I would start doing ultra tests if this was shown to make a difference in diagnosis.

REPLY
@rocky999

Hi

Gleason 9
Decipher 0.99

RP followed with persistent PSA then SR and 6 months Lupron. 2 weeks later PSA undetectable and T=4.

My health provider wants me to do a total of 18 mos ADT ( ie 12 mos more). Got a second opinion from a “center of excellence “ and they said 6 mos( ie no more). It’s a tough one for a guy on the street to make this decision. My reading says that the benefits of long ADT is constantly described as a grey area but the systemic side effects of long ADT are well documented. On that basis I have opted for the 6 mos (which I have completed) with a monthly PSA/T/blood panel test from hereon to catch anything if it twitches. Then I will be open to going back on ADT. So maybe I will be on Intermittent ADT which has been described in studies as “non-inferior” . The other murkier are I have read about is the selection pressure that intense ADT can put on the PC cells pushing them towards castrate resistance. So maybe intermittent ADT might be helpful? Being new to the PC club ie everything has happened this year I am a bit shocked at all the grey areas and highland mists that surround this particular cancer….
Des

Jump to this post

It's a new year and I'm in a funk, I'm 77 had chemotherapy 18 months ago then ADT for a year my PSA is undetectable .01 and have been taken off my luperon now for 4 months won't see the doc for another 2 months. I've talked to several RO'S with the same advise PSA undetectable let it be, never had any side effects from any treatment except fatigue and that's the rub on me. I've always been active living in Utah did a lot of back country with my dog's. Sorry for the run on I'm just happy to still be here.

REPLY

Your description is much like mine except I am now 85.
Resumed PSA after a couple of years with none at Dr.'s request. PSA @ 12. Dr. comment "could be false reading " - 3 mo. later at 50. All 12 biopsy samples filled with cancer. Had spread to lymph nodes, but not to bones. Started ADT and six mo. later had a month's worth of radiation (daily). PSA went down to undetectable. On ADT for 2 1/2 years. Stopped June of 2023.

6 mo. out still have fatigue and brain fog. loss of muscle, etc. PSA is undetectable but so is testosterone.

Scheduled for testosterone therapy next month to help with weakness and hopefully brain fog. Will post again in 6 months

REPLY
@heavyphil

Unfortunately, Rocky, it IS a crapshoot when it comes to actually ‘seeing’ what’s going on at a cellular level.
PSA’s and PSMA’s are NOT infallible - not even close - but right now it’s what they use to measure success or failure.
I read your brief history and in spite of all the intense genetic testing you had done at the center of excellence, the factors which stand out to me the most are your dangerously high Decipher Score and PSA velocity after surgery.
My surgical pathology was Gleason 4+3, clean margins, no lymph spread, etc. There was no Decipher test at that time. It took 5 years for my PSA to reach .18 and I just finished salvage radiation and am on 6 months ORGOVYX ( last month).
Now if I’m on 6 months ADT for something that took 5 YEARS to return, how long should you be on it, when your PSA rose so quickly after surgery and your Decipher Score showed such an aggressive profile?
It would seem to me as a layman that all things being equal, you should be on it longer than 6 months….how long I certainly don’t know. Orgovyx is really not that bad and others on the forum have been on it for over a year with no significant side effects. I realize you are concerned with your situation becoming castrate resistant if you stay on ADT too long but I think you’d have to be on it for a much longer time for that to happen. Best…

Jump to this post

Hi Heavy Phil
It took awhile to find the phrase “ persistent PSA” as compared to “ BCR”. My 0.31 reading at 3 mos post surgery was pretty fast for a BCR and the theory is that something was left behind after surgery despite clear margins and no lymph node involvement. Hence 6mo ADT 4mos after surgery and 37 radiation sessions 5 mos after surgery. I know that my risk of BCR within 10 yrs is very high from the Decipher reading but I don’t know that 24mos of ADT will be a significant benefit over 6mos with monthly monitoring . The four oncologists that I met with all used the phrase “grey area” on longterm ADT. The other murkier area is the advisability of putting high pressure on relatively unstable cancer cells by taking away all their testosterone for a prolonged period and pushing them to castrate resistance sooner.
Having said all that I just don’t know if I will become a cautionary tale! I still find it a bit astounding that there isnt more definitive data for the range of risk stratifications of PC. From my reading I would guess that a lack of early risk stratification protocol by urology practitioners over decades has a lot to do with this. Sorry about getting on my hobby horse but I think aggressive PC should be called something different than low risk PC…..

REPLY
@jeffmarc

Interesting point you bring up. Unfortunately there is no answer today, hopefully this is being studied. An awful lot of people want an answer to this, I would start doing ultra tests if this was shown to make a difference in diagnosis.

Jump to this post

I don't think ultrasensitive PSA makes a difference if your PSA is already detectable; the main benefit is that "undetectable" becomes a lower (and thus, more-confident) number, by at least an order of magnitude.

Do U.S. insurers routinely cover the uPSA test, or do you have to kick up a fuss? I originally had mine done at a private lab, so I was forced to wait 2–3 days to get the result. Now I just walk to the hospital lab itself (same distance), and see the result in my online chart in 1–3 hours instead.

REPLY
@northoftheborder

I don't think ultrasensitive PSA makes a difference if your PSA is already detectable; the main benefit is that "undetectable" becomes a lower (and thus, more-confident) number, by at least an order of magnitude.

Do U.S. insurers routinely cover the uPSA test, or do you have to kick up a fuss? I originally had mine done at a private lab, so I was forced to wait 2–3 days to get the result. Now I just walk to the hospital lab itself (same distance), and see the result in my online chart in 1–3 hours instead.

Jump to this post

My oncologist offered to let me have the more sensitive test, but said that it takes two or three days because they have to send them out. It wouldn’t cost me any more. I get almost all my other blood test results within 2 hours, But the PSA test always takes till late in the afternoon or the next morning.

In my case undetectable is a temporary thing, eventually Nubeqa will fail and I will have to move to a PARP inhibitor. Getting A more sensitive test is just not much of a benefit to me, I need to be concerned when it is .1 or higher and how quickly it is moving.

For those that may be in remission, the test is more useful. It definitely gives confidence knowing the number is so small.

REPLY
@rocky999

Hi Heavy Phil
It took awhile to find the phrase “ persistent PSA” as compared to “ BCR”. My 0.31 reading at 3 mos post surgery was pretty fast for a BCR and the theory is that something was left behind after surgery despite clear margins and no lymph node involvement. Hence 6mo ADT 4mos after surgery and 37 radiation sessions 5 mos after surgery. I know that my risk of BCR within 10 yrs is very high from the Decipher reading but I don’t know that 24mos of ADT will be a significant benefit over 6mos with monthly monitoring . The four oncologists that I met with all used the phrase “grey area” on longterm ADT. The other murkier area is the advisability of putting high pressure on relatively unstable cancer cells by taking away all their testosterone for a prolonged period and pushing them to castrate resistance sooner.
Having said all that I just don’t know if I will become a cautionary tale! I still find it a bit astounding that there isnt more definitive data for the range of risk stratifications of PC. From my reading I would guess that a lack of early risk stratification protocol by urology practitioners over decades has a lot to do with this. Sorry about getting on my hobby horse but I think aggressive PC should be called something different than low risk PC…..

Jump to this post

Seems like GRAY should be the color of OUR lapel pin, right? I hear what you’re saying and I just can’t help but think of all the men who had this disease decades ago and were in the hands of urologists who really had no idea how this disease should be treated, let alone classified.
And even further, how many old time GP’s didn’t even refer patients to urologists? In fact, even the PSA test is relatively ‘new’ and STILL controversial!
I read recently that Rick Steves, famed TV personality/tour guide was diagnosed with PCa after having his FIRST PSA TEST at age 68. I thought I had read the article incorrectly but no, his doctor never did one…WTF??!!
Sorry to digress, but my point (I think!) is that even today there is no real consistency of thought when it comes to most cancers. Even in breast cancer they want to declassify ductile carcinoma in situ as ‘non cancerous’ and give it a different name since it is rarely invasive….rarely….
In your situation perhaps ‘plain old’ ADT is not the answer. Many have spoken about germ and somatic genetic testing (not Decipher) giving greater insight into what their cancer would/would not respond to down the road should it return (BRCA2). I guess you already know that its propensity to become castrate resistant is higher due to your Decipher score.
So maybe instead of staying on ADT longer and wasting time, a more proactive approach using different drugs might be more appropriate? Yeah, here you want off of ADT and I’m suggesting even more treatment - NOT what you want to hear, nor would I. But as you say, you don’t want to be the star in a precautionary tale either. What can I say? It is indeed a gray area😖 and a frustrating one for patients!

REPLY
Please sign in or register to post a reply.